Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Foden
C. Foden
London Health Sciences Centre
Medicine
Lymphoma
Chemotherapy
Celecoxib
Immunology
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Palliation of relapsed aggressive histology NHL with high-dose celecoxib and 'metronomic' low-dose cyclophosphamide
2004
Journal of Clinical Oncology
Rena Buckstein
Michael Crump
Yuval Shaked
C. Foden
Rakesh Nayar
Diane E. Taylor
Francesco Bertolini
Sylvain Baruchel
Shan Man
Robert S. Kerbel
Show All
Source
Cite
Save
Citations (6)
Rituximab + ESHAP as Salvage Chemotherapy for Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma: A Phase II Trial.
2004
Blood
Lisa Hicks
R. Buckstein
E. Piliotis
Joy Mangel
K. Imrie
D. E. Spaner
M. D. Reis
C. Foden
V. Milliken
A. Boudreau
P. Richardson
N. Pennell
N. Berinstein
Show All
Source
Cite
Save
Citations (3)
High Dose Celecoxib and Metronomic ‘Low-Dose’ Cyclophosphamide Is Effective Therapy in Patients with Relapsed and Refractory Aggressive Histology NHL.
2004
Blood
Rena Buckstein
Michael Crump
Yuval Shaked
David Spaner
Eugenia Piliotis
Kevin Imrie
Rakesh Nayar
C. Foden
Ruth Turner
Diane E. Taylor
Shan Man
Sylvain Baruchel
Diana Stempak
Ian Quirt
J Sturgeon
Francesco Bertolini
Robert S. Kerbel
Show All
Source
Cite
Save
Citations (1)
Surveillance of serum immunoglobulins after high-dose therapy/ASCT plus post-transplant consolidative Rituximab for relapsed follicular and new-diagnosis mantle cell lymphoma
2003
Blood
Anthony Woods
W. Lam
Neil L. Berinstein
Joy Mangel
Kevin Imrie
David Spaner
A. Boudreau
Michael Crump
C. Foden
Rena Buckstein
Show All
Source
Cite
Save
Citations (1)
1